Conclusions
depression
REMISSION
The results of this randomized clinical trial suggest that SA over 6 weeks is feasible and safe. Although the differences between SA and NSA groups did not reach statistical significance for the primary outcome, SA did produce greater symptom remission at 3 months. A more extensive sample size study, more protracted intervention, and objective evaluation of the results are necessary to further investigate the efficacy of SA for depression.